Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Guyana Health Review.
Press releases published on August 1, 2025
BioXcel Therapeutics Announces Last Patient Last Visit in SERENITY At-Home Pivotal Phase 3 Safety Trial for Acute Treatment of Agitation Associated with Bipolar Disorders or Schizophrenia
GlobeNewswire
·
August 1, 2025
Vast majority of patients dosed completed the full 12-week study Data from more than 2,200 agitation episodes collected Topline data readout anticipated this month NEW HAVEN, Conn., Aug. 01, 2025 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI …
Medicenna Therapeutics Reports First Quarter Fiscal 2026 Financial Results and Operational Highlights
GlobeNewswire
·
August 1, 2025
Updated cash guidance provides runway into at least the middle of calendar 2026 Company remains encouraged by MDNA11 clinical results presented to-date, demonstrating best-in-class potential of our IL-2 superkine by exceeding ORR benchmarks demonstrated …
ANI Pharmaceuticals to Discuss Second Quarter 2025 Financial Results on August 8, 2025, at 8:30 a.m. ET
GlobeNewswire
·
August 1, 2025
PRINCETON, N.J., Aug. 01, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its second quarter 2025 financial results on Friday, August 8, 2025, prior to the market open …
Regeneron Reports Second Quarter 2025 Financial and Operating Results
GlobeNewswire
·
August 1, 2025
Second quarter 2025 revenues increased 4% to $3.68 billion versus second quarter 2024 Dupixent® global net sales (recorded by Sanofi) increased 22% to $4.34 billion EYLEA HD® U.S. net sales increased 29% to $393 million; total EYLEA HD and EYLEA® U.S. net …
BrightSpring Health Services, Inc. Reports Second Quarter 2025 Financial Results and Increases Full Year 2025 Guidance
GlobeNewswire
·
August 1, 2025
LOUISVILLE, Ky., Aug. 01, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG), a leading provider of home and community-based health services for complex populations, today announced financial …
Oculis Upsized Loan Facility to Access up to CHF 100 million
GlobeNewswire
·
August 1, 2025
ZUG, Switzerland, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic diseases with significant unmet …
Diplomatic Trade Ltd, Thomas J. Kent Jr. the Kent Family Office, and Kent Global LLC Stake Acquisition in Turkish Pharma Firm, Target $300M UAE Biopharma Venture
GlobeNewswire
·
August 1, 2025
Thomas J. Kent Jr. DUBAI, United Arab Emirates, July 31, 2025 (GLOBE NEWSWIRE) -- Diplomatic Trade Ltd and Kent Global Support Strategic Stake in Turkish Pharma Group, Plan $300M UAE Biopharma Initiative Cross-border biopharma venture targets UAE facility …
Silexion Therapeutics Announces Exercise of Warrants for $1.8 Million Gross Proceeds
GlobeNewswire
·
August 1, 2025
Cayman Islands, July 31, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion Therapeutics” or the “Company”), a clinical-stage biotech company developing RNA interference (RNAi) therapies for KRAS-driven cancers, today announced …